PURPOSE: The aim of this study was to investigate correlations between glucose metabolism as determined by [(18)F]FDG PET/CT and tumour perfusion as quantified by volume perfusion CT in primary tumours and mediastinal lymph nodes (MLN) of patients with non-small-cell lung cancer (NSCLC). METHODS: Enrolled in the study were 17 patients with NSCLC. [(18)F]FDG uptake was quantified in terms of SUVmax and SUVavg. Blood flow (BF), blood volume (BV) and flow extraction product (K(trans)) were determined as perfusion parameters. The correlations between the perfusion parameters and [(18)F]FDG uptake values were subsequently evaluated. RESULTS: For the primary tumours, no correlations were found between perfusion parameters and [(18)F]FDG uptake. In MLN, there were negative correlations between BF and SUVavg (r = -0.383), BV and SUVavg (r = -0.406), and BV and SUVmax (r = -0.377), but not between BF and SUVmax, K(trans) and SUVavg, or K(trans) and SUVmax. Additionally, in MLN with SUVmax >2.5 there were negative correlations between BF and SUVavg (r = -0.510), BV and SUVavg (r = -0.390), BF and SUVmax (r = -0.536), as well as BV and SUVmax (r = -0.346). CONCLUSION: Perfusion and glucose metabolism seemed to be uncoupled in large primary tumours, but an inverse correlation was observed in MLN. This information may help improve therapy planning and response evaluation.
PURPOSE: The aim of this study was to investigate correlations between glucose metabolism as determined by [(18)F]FDG PET/CT and tumour perfusion as quantified by volume perfusion CT in primary tumours and mediastinal lymph nodes (MLN) of patients with non-small-cell lung cancer (NSCLC). METHODS: Enrolled in the study were 17 patients with NSCLC. [(18)F]FDG uptake was quantified in terms of SUVmax and SUVavg. Blood flow (BF), blood volume (BV) and flow extraction product (K(trans)) were determined as perfusion parameters. The correlations between the perfusion parameters and [(18)F]FDG uptake values were subsequently evaluated. RESULTS: For the primary tumours, no correlations were found between perfusion parameters and [(18)F]FDG uptake. In MLN, there were negative correlations between BF and SUVavg (r = -0.383), BV and SUVavg (r = -0.406), and BV and SUVmax (r = -0.377), but not between BF and SUVmax, K(trans) and SUVavg, or K(trans) and SUVmax. Additionally, in MLN with SUVmax >2.5 there were negative correlations between BF and SUVavg (r = -0.510), BV and SUVavg (r = -0.390), BF and SUVmax (r = -0.536), as well as BV and SUVmax (r = -0.346). CONCLUSION: Perfusion and glucose metabolism seemed to be uncoupled in large primary tumours, but an inverse correlation was observed in MLN. This information may help improve therapy planning and response evaluation.
Authors: G Schmid-Bindert; Thomas Henzler; T Q Chu; M Meyer; J W Nance; U J Schoepf; D J Dinter; P Apfaltrer; R Krissak; C Manegold; S O Schoenberg; C Fink Journal: Eur Radiol Date: 2011-08-07 Impact factor: 5.315
Authors: J F Vansteenkiste; S G Stroobants; P J Dupont; P R De Leyn; W F De Wever; E K Verbeken; J L Nuyts; F P Maes; J G Bogaert Journal: Eur J Nucl Med Date: 1998-11
Authors: Quynh-Thu Le; Eunice Chen; Ali Salim; Hongbin Cao; Christina S Kong; Richard Whyte; Jessica Donington; Walter Cannon; Heather Wakelee; Robert Tibshirani; John D Mitchell; Donna Richardson; Ken J O'Byrne; Albert C Koong; Amato J Giaccia Journal: Clin Cancer Res Date: 2006-03-01 Impact factor: 12.531
Authors: Corneline J Hoekstra; Sigrid G Stroobants; Otto S Hoekstra; Egbert F Smit; Johan F Vansteenkiste; Adriaan A Lammertsma Journal: Clin Cancer Res Date: 2002-07 Impact factor: 12.531
Authors: Vikram Rao Bollineni; Erwin M Wiegman; Jan Pruim; Harry J M Groen; Johannes A Langendijk Journal: Cancer Treat Rev Date: 2012-05-04 Impact factor: 12.111
Authors: Dan J Raz; Jason A Zell; S-H Ignatius Ou; David R Gandara; Hoda Anton-Culver; David M Jablons Journal: Chest Date: 2007-05-15 Impact factor: 9.410
Authors: P Veit-Haibach; D De Ruysscher; W van Elmpt; M Das; Martin Hüllner; H Sharifi; K Zegers; B Reymen; P Lambin; J E Wildberger; E G C Troost Journal: Radiother Oncol Date: 2013-09-14 Impact factor: 6.280
Authors: José Pablo Martínez Barbero; Inmaculada Rodríquez Jiménez; Teodoro Martin Noguerol; Antonio Luna Alcalá Journal: Cancers (Basel) Date: 2013-07-05 Impact factor: 6.639
Authors: Martin W Huellner; Timothy D Collen; Philipp Gut; Ralph Winterhalder; Chantal Pauli; Joachim Diebold; Burkhardt Seifert; Klaus Strobel; Patrick Veit-Haibach Journal: EJNMMI Res Date: 2014-01-22 Impact factor: 3.138
Authors: Jung Im Kim; Hyun-Ju Lee; Young Jae Kim; Kwang Gi Kim; Kyung Won Lee; Jae Ho Lee; Hak Jong Lee; Won Woo Lee Journal: ScientificWorldJournal Date: 2014-10-15
Authors: Ramasamy Paulmurugan; Bryan Oronsky; Chad F Brouse; Tony Reid; Susan Knox; Jan Scicinski Journal: Theranostics Date: 2013-05-25 Impact factor: 11.556
Authors: Wouter van Elmpt; Catharina M L Zegers; Bart Reymen; Aniek J G Even; Anne-Marie C Dingemans; Michel Oellers; Joachim E Wildberger; Felix M Mottaghy; Marco Das; Esther G C Troost; Philippe Lambin Journal: Eur J Nucl Med Mol Imaging Date: 2015-09-04 Impact factor: 9.236